tiprankstipranks
Trending News
More News >
Global Health Limited (IN:MEDANTA)
:MEDANTA
India Market

Global Health Limited (MEDANTA) Stock Forecast & Price Target

Compare
5 Followers
See the Price Targets and Ratings of:

MEDANTA Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Global
Health Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MEDANTA Stock 12 Month Forecast

There Are No Analyst Ratings for IN:MEDANTA In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MEDANTA Financial Forecast

MEDANTA Earnings Forecast

Next quarter’s earnings estimate for MEDANTA is ₹5.20 with a range of ₹4.80 to ₹5.60. The previous quarter’s EPS was ₹5.70. MEDANTA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year MEDANTA has Performed in-line its overall industry.
Next quarter’s earnings estimate for MEDANTA is ₹5.20 with a range of ₹4.80 to ₹5.60. The previous quarter’s EPS was ₹5.70. MEDANTA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year MEDANTA has Performed in-line its overall industry.

MEDANTA Sales Forecast

Next quarter’s sales forecast for MEDANTA is ₹10.78B with a range of ₹10.68B to ₹10.96B. The previous quarter’s sales results were ₹10.99B. MEDANTA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year MEDANTA has Performed in-line its overall industry.
Next quarter’s sales forecast for MEDANTA is ₹10.78B with a range of ₹10.68B to ₹10.96B. The previous quarter’s sales results were ₹10.99B. MEDANTA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year MEDANTA has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on IN:MEDANTA
Jefferies
Jefferies
₹1,380₹1,530
Buy
25.76%
Upside
Reiterated
08/12/25
Jefferies Sticks to Their Buy Rating for Global Health Limited (MEDANTA)
HSBC
₹965₹1,200
Sell
-1.37%
Downside
Reiterated
08/11/25
HSBC Reaffirms Their Sell Rating on Global Health Limited (MEDANTA)
J.P. Morgan Analyst forecast on IN:MEDANTA
J.P. Morgan
J.P. Morgan
₹1,240₹1,480
Hold
21.65%
Upside
Reiterated
08/11/25
J.P. Morgan Keeps Their Hold Rating on Global Health Limited (MEDANTA)
Kotak Mahindra Analyst forecast on IN:MEDANTA
Kotak Mahindra
Kotak Mahindra
₹1,275₹1,460
Buy
20.00%
Upside
Reiterated
08/11/25
Kotak Mahindra Remains a Buy on Global Health Limited (MEDANTA)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on IN:MEDANTA
Jefferies
Jefferies
₹1,380₹1,530
Buy
25.76%
Upside
Reiterated
08/12/25
Jefferies Sticks to Their Buy Rating for Global Health Limited (MEDANTA)
HSBC
₹965₹1,200
Sell
-1.37%
Downside
Reiterated
08/11/25
HSBC Reaffirms Their Sell Rating on Global Health Limited (MEDANTA)
J.P. Morgan Analyst forecast on IN:MEDANTA
J.P. Morgan
J.P. Morgan
₹1,240₹1,480
Hold
21.65%
Upside
Reiterated
08/11/25
J.P. Morgan Keeps Their Hold Rating on Global Health Limited (MEDANTA)
Kotak Mahindra Analyst forecast on IN:MEDANTA
Kotak Mahindra
Kotak Mahindra
₹1,275₹1,460
Buy
20.00%
Upside
Reiterated
08/11/25
Kotak Mahindra Remains a Buy on Global Health Limited (MEDANTA)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Global Health Limited

3 Months
xxx
Success Rate
1/4 ratings generated profit
25%
Average Return
+0.05%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of +0.05% per trade.
1 Year
Success Rate
2/4 ratings generated profit
50%
Average Return
+5.27%
reiterated a sell rating 5 months ago
Copying Damayanti Kerai's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.27% per trade.
2 Years
xxx
Success Rate
2/4 ratings generated profit
50%
Average Return
+2.45%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +2.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MEDANTA Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
0
0
0
0
0
Buy
5
6
5
4
2
Hold
1
2
1
1
1
Sell
2
3
2
1
0
Strong Sell
0
0
0
0
0
total
8
11
8
6
3
In the current month, MEDANTA has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MEDANTA average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

MEDANTA Stock Forecast FAQ

What is IN:MEDANTA’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:MEDANTA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:MEDANTA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Global Health Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Global Health Limited’s share price target?
      Currently, no data Available
      What do analysts say about Global Health Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Global Health Limited?
      To buy shares of IN:MEDANTA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.